Population pharmacokinetic/pharmacodynamic analysis of the DPP-4 inhibitor linagliptin in Japanese patients with type 2 diabetes mellitus.
about
Population pharmacokinetic/pharmacodynamic analysis of the DPP-4 inhibitor linagliptin in Japanese patients with type 2 diabetes mellitus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Population pharmacokinetic/pha ...... with type 2 diabetes mellitus.
@en
Population pharmacokinetic/pha ...... with type 2 diabetes mellitus.
@nl
type
label
Population pharmacokinetic/pha ...... with type 2 diabetes mellitus.
@en
Population pharmacokinetic/pha ...... with type 2 diabetes mellitus.
@nl
prefLabel
Population pharmacokinetic/pha ...... with type 2 diabetes mellitus.
@en
Population pharmacokinetic/pha ...... with type 2 diabetes mellitus.
@nl
P2093
P356
P1476
Population pharmacokinetic/pha ...... with type 2 diabetes mellitus
@en
P2093
Akiko Sarashina
Alexander Staab
Mikihisa Takano
Shinji Tatami
Silke Retlich
Yasuhiro Tsuda
Yusuke Tadayasu
P304
P356
10.18433/J3S304
P407
P50
P577
2013-01-01T00:00:00Z